Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “Myelodysplastic syndrome”
A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02848001. IPD Sharing: Not stated. Countries: 6. Publications: 1.
An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01751867. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00379912. IPD Sharing: NO. Countries: 1. Publications: 1.
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT01904136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00939159. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Luspatercept for the Treatment of Anemia in Patients With Myelodysplastic Syndrome (MDS) (MK-6143-001)
ClinicalTrials.gov study NCT01749514. IPD Sharing: YES. Countries: 1. Publications: 2.
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00102687. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clofarabine for Myelodysplastic Syndrome (MDS) Patients Who Failed Vidaza Treatment (tx)
ClinicalTrials.gov study NCT00700011. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03772925. IPD Sharing: YES. Countries: 1. Publications: 1.
Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02103478. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)
ClinicalTrials.gov study NCT01736683. IPD Sharing: YES. Countries: 2. Publications: 1.
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02807558. IPD Sharing: NO. Countries: 2. Publications: 1.
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00313586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02890329. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02158936. IPD Sharing: Not stated. Countries: 30. Publications: 1.
Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00352001. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00961064. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02670525. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
ClinicalTrials.gov study NCT00812968. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT04313881. IPD Sharing: NO. Countries: 21. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.